Press Releases

SAN DIEGO, Dec. 5, 2019 /PRNewswire/ -- Epic Sciences, Inc. today announced the presentation of new data demonstrating the feasibility of using its proprietary technology for the d

MANSFIELD, Mass., Dec. 5, 2019 /PRNewswire/ -- Transplant Genomics, Inc. ("TGI"), a molecular diagnostics company committed to improving organ transplant outcomes with non-invasive serial monitoring guided by genomics, today received notice that the Molecular Diagnostics Services (MolDX) Program developed by Palmetto GBA has set TruGraf reimbursement at

STAMFORD, Conn., Dec. 5, 2019 /PRNewswire/ -- Leading science-based medical communications agency, The Lockwood Group (Lockwood), was recognized for the second year as a

BOSTON, Dec. 5, 2019 /PRNewswire/ -- Samus Therapeutics, Inc. ("Samus" or the "Company"), a privately held, Boston-based, biopharmaceutical company developing epichaperome inhibitors  to intervene in pathological processes and initiate the degradation of disease-associated proteins, today announced the presentation of initi

WOBURN, Mass., Dec. 5, 2019 /PRNewswire/ -- Bio2 Technologies, Inc., a privately held orthopedic implant company, announced today that Ted Bird and David Gill have been appointed to the Company's board of directors.  "We are excited to have Ted and David join our board

CHICAGO, Dec. 5, 2019 /PRNewswire/ -- Hub International Limited (Hub), a leading global insurance brokerage, announced today that it has acquired the assets of Blair Jarcik

TUCSON, Ariz., Dec. 5, 2019 /PRNewswire/ --ARDS (Acute Respiratory Distress Syndrome) represents ~488K US cases/yr; with >30% mortality from a highly inflammatory lung disorder without FDA-approved drugs. The anticipated U.S. market is $2.8B. ALT was awarded a $1.7M NIH Fast Track STTR Phase I/II grant

PASADENA, Calif., Dec. 5, 2019 /PRNewswire/ -- NextGate, the global leader in healthcare enterprise identification, announced today that the California County of Monte

BLANCHARDVILLE, Wis., Dec. 5, 2019 /PRNewswire/ -- A new study reports high levels of patient satisfaction with a minimally invasive approach to creating vascular access for kidney patients who require hemodialysis. In addition, the researchers found that nearly all the dialysis access sites, or fistulas, were still functional after two years - a significant improve

NEW YORK, Dec. 5, 2019 /PRNewswire/ -- Healthcare Trust, Inc. ("HTI" or the "Company") today announced the launch of a proposed underwritten public offering of 1,400,000 shares of its Series A Cumulative Redeemable Perpetual Preferred Stock (the "Series A Preferred Stock"), pursuant to a registration statement on Form S-11 filed with the Securities an